亚太药业
(002370)
| 流通市值：50.18亿 | | | 总市值：50.18亿 |
| 流通股本：7.46亿 | | | 总股本：7.46亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 586,461,867.98 | 618,719,305.59 | 587,809,931.97 | 625,177,565.07 |
| 交易性金融资产 | 30,055,997.81 | - | 30,082,329.42 | - |
| 应收票据及应收账款 | 95,596,113.21 | 91,415,725.07 | 103,548,761.89 | 96,912,265.35 |
| 其中：应收票据 | - | 0 | - | - |
| 应收账款 | 95,596,113.21 | 91,415,725.07 | 103,548,761.89 | 96,912,265.35 |
| 应收款项融资 | 29,920,118.52 | 63,633,932.59 | 28,969,559.17 | 35,415,795.84 |
| 预付款项 | 2,487,019.28 | 4,036,888.6 | 1,346,589.33 | 1,212,353.75 |
| 其他应收款合计 | 614,467.95 | 530,189.96 | 3,309,405.58 | 719,557.06 |
| 其中:应收利息 | - | - | 2,730,243.04 | 165,000 |
| 存货 | 100,942,956.17 | 107,251,421.94 | 52,774,054.96 | 68,697,542.16 |
| 其他流动资产 | 11,978,532.34 | 12,686,882.61 | 8,142,638.68 | 8,824,454.12 |
| 流动资产合计 | 858,057,073.26 | 898,274,346.36 | 815,983,271 | 836,959,533.35 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 36,307,834.05 | 38,012,170.63 | 36,689,365.37 | 39,108,543.87 |
| 固定资产 | 289,304,351.18 | 294,713,969.12 | 300,034,190.33 | 304,887,691.33 |
| 在建工程 | 1,051,080.64 | 16,093 | 1,457,149.83 | 552,500 |
| 无形资产 | 42,712,766.3 | 44,001,051.86 | 43,291,544.3 | 44,658,478.28 |
| 开发支出 | 5,453,101.9 | 4,698,384.92 | 16,463,412.82 | 16,463,412.82 |
| 长期待摊费用 | - | - | 28,080 | 56,160 |
| 非流动资产合计 | 374,829,134.07 | 381,441,669.53 | 397,963,742.65 | 405,726,786.3 |
| 资产总计 | 1,232,886,207.33 | 1,279,716,015.89 | 1,213,947,013.65 | 1,242,686,319.65 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 76,835,217.14 | 103,966,984.16 | 50,020,424.53 | 69,063,495.48 |
| 其中：应付票据 | 60,312,032.5 | 60,312,032.5 | 15,348,965 | 33,887,283.7 |
| 应付账款 | 16,523,184.64 | 43,654,951.66 | 34,671,459.53 | 35,176,211.78 |
| 合同负债 | 14,155,462.75 | 14,746,447.04 | 2,138,035.77 | 2,188,118.63 |
| 应付职工薪酬 | 6,194,273.57 | 13,133,450.16 | 7,600,219.47 | 6,794,698.13 |
| 应交税费 | 1,631,664.17 | 5,146,980.69 | 1,965,646.47 | 3,320,837.95 |
| 其他应付款合计 | 7,873,822.7 | 13,325,849.4 | 17,455,571.62 | 18,063,999.59 |
| 一年内到期的非流动负债 | - | - | - | 0 |
| 其他流动负债 | 1,840,210.17 | 1,917,038.07 | 277,944.65 | 284,455.42 |
| 流动负债合计 | 108,530,650.5 | 152,236,749.52 | 79,457,842.51 | 99,715,605.2 |
| 非流动负债: | | | | |
| 应付债券 | - | - | - | 0 |
| 预计负债 | - | - | 6,037,827.67 | 6,037,827.67 |
| 递延收益 | 2,927,570.98 | 3,210,884.32 | 3,494,197.66 | 3,777,511 |
| 递延所得税负债 | 3,725,848.24 | 3,981,498.73 | 3,783,077.92 | 3,999,850.29 |
| 非流动负债合计 | 6,653,419.22 | 7,192,383.05 | 13,315,103.25 | 13,815,188.96 |
| 负债合计 | 115,184,069.72 | 159,429,132.57 | 92,772,945.76 | 113,530,794.16 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 745,667,530 | 745,667,530 | 745,667,530 | 745,667,530 |
| 资本公积 | 2,005,019,330.65 | 2,005,016,546.65 | 2,005,016,546.65 | 2,005,016,546.65 |
| 盈余公积 | 60,559,514.31 | 60,559,514.31 | 60,559,514.31 | 60,559,514.31 |
| 未分配利润 | -1,693,544,237.35 | -1,690,956,707.64 | -1,690,069,523.07 | -1,682,088,065.47 |
| 归属于母公司股东权益合计 | 1,117,702,137.61 | 1,120,286,883.32 | 1,121,174,067.89 | 1,129,155,525.49 |
| 股东权益合计 | 1,117,702,137.61 | 1,120,286,883.32 | 1,121,174,067.89 | 1,129,155,525.49 |
| 负债和股东权益合计 | 1,232,886,207.33 | 1,279,716,015.89 | 1,213,947,013.65 | 1,242,686,319.65 |
| 公告日期 | 2026-04-25 | 2026-04-25 | 2025-10-29 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |